Security Snapshot

ISHARES TR - U.S. MED DVC ETF (IHI) Institutional Ownership

CUSIP: 464288810

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

547

Shares (Excl. Options)

27,420,495

Price

$62.15

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / U.S. MED DVC ETF
Symbol
IHI
Price per share
$53.24
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
27,420,495
Total reported value
$1,704,801,227
% of total 13F portfolios
0.01%
Share change
-1,538,686
Value change
-$94,198,127
Number of holders
547
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • IHI - ISHARES TR - U.S. MED DVC ETF is tracked under CUSIP 464288810.
  • 547 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 547 to 324 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,704,801,227 to $679,849,732.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 547 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 464288810?
CUSIP 464288810 identifies IHI - ISHARES TR - U.S. MED DVC ETF in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 547 institutional investors reported holding 27,420,495 shares of ISHARES TR - U.S. MED DVC ETF (IHI).

Institutional Holders of ISHARES TR - U.S. MED DVC ETF (IHI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 12,738,893 $679,849,732 +$39,498,308 $53.35 324
2025 Q4 27,420,495 $1,704,801,227 -$94,198,127 $62.15 547
2025 Q3 28,066,095 $1,686,567,273 -$139,681,287 $60.08 519
2025 Q2 30,890,113 $1,934,078,245 -$71,129,888 $62.64 541
2025 Q1 32,041,775 $1,926,739,389 +$243,060,259 $60.19 549
2024 Q4 28,259,914 $1,650,015,884 -$370,655,958 $58.35 559
2024 Q3 34,262,358 $2,029,447,469 -$225,531,189 $59.22 550
2024 Q2 38,245,282 $2,143,068,382 -$86,251,564 $56.04 541
2024 Q1 39,518,066 $2,313,517,861 +$2,461,048 $58.59 576
2023 Q4 40,428,388 $2,182,412,405 -$55,966,831 $53.97 572
2023 Q3 41,264,588 $2,005,645,231 +$109,175,798 $48.50 539
2023 Q2 38,686,875 $2,181,537,226 -$172,775,979 $56.46 580
2023 Q1 41,867,910 $2,260,877,671 -$12,203,369 $53.98 550
2022 Q4 42,031,865 $2,211,056,470 -$45,315,080 $52.57 567
2022 Q3 43,464,582 $2,055,482,136 -$234,169,711 $47.18 542
2022 Q2 48,569,498 $2,448,683,360 +$15,986,913 $50.44 579
2022 Q1 47,889,171 $2,918,872,393 -$350,481,234 $60.96 622
2021 Q4 53,812,177 $3,539,114,281 +$81,661,366 $65.85 653
2021 Q3 49,806,746 $3,128,547,092 +$2,508,306,462 $62.78 564
2021 Q2 7,826,817 $2,826,778,825 -$1,137,455,368 $361.04 536
2021 Q1 11,686,783 $3,876,852,987 -$1,081,044,875 $330.36 561
2020 Q4 14,983,493 $4,910,407,530 +$110,672,621 $327.30 575
2020 Q3 14,494,165 $4,339,229,620 +$456,702,348 $299.62 482
2020 Q2 12,995,633 $3,443,480,026 +$1,394,578,161 $264.77 459
2020 Q1 7,705,659 $1,737,317,696 -$157,814,017 $225.35 358
2019 Q4 8,139,148 $2,151,439,880 +$22,823,971 $264.32 376
2019 Q3 8,076,810 $1,996,063,373 +$116,313,139 $247.23 312
2019 Q2 7,613,929 $1,832,788,402 +$8,518,611 $240.72 291
2019 Q1 7,578,758 $1,754,189,772 +$319,042,377 $231.53 266
2018 Q4 6,256,494 $1,249,925,581 -$250,468,417 $199.81 229
2018 Q3 7,345,896 $1,670,720,723 +$295,357,397 $227.48 225
2018 Q2 6,038,961 $1,211,402,838 +$288,823,941 $200.65 187
2018 Q1 4,605,252 $851,668,108 +$75,523,046 $185.01 170
2017 Q4 4,201,986 $729,318,026 -$22,018,662 $173.51 170
2017 Q3 4,198,388 $701,394,684 -$102,158,472 $167.03 152
2017 Q2 5,014,171 $833,466,094 +$276,958,082 $166.61 158
2017 Q1 3,303,802 $500,691,640 +$44,034,893 $151.42 137
2016 Q4 3,708,859 $494,781,026 -$404,210,376 $133.15 107
2016 Q3 6,663,640 $968,079,692 +$112,818,089 $145.39 120
2016 Q2 5,945,139 $805,981,791 +$209,116,207 $135.55 108
2016 Q1 4,353,811 $533,325,007 +$105,363,620 $122.48 86
2015 Q4 3,500,375 $428,477,854 -$45,909,878 $122.47 83
2015 Q3 3,866,524 $431,020,000 -$612,061 $111.29 80
2015 Q2 3,873,425 $463,914,273 -$43,550,470 $119.73 73
2015 Q1 4,279,973 $514,766,818 -$18,272,616 $120.29 75
2014 Q4 4,449,955 $503,398,772 +$91,171,916 $113.11 79
2014 Q3 2,244,139 $223,076,246 +$1,398,615 $99.40 65
2014 Q2 2,226,745 $227,170,440 +$3,341,561 $102.02 69
2014 Q1 2,193,592 $216,544,433 +$33,508,508 $98.81 60
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .